Cutera Announces Expansion of FDA Indications for the truSculpt® Body Contouring System
"TruSculpt’s approval for lipolysis is exciting in two ways,” said Dr.
“Today’s announcement is a major milestone for our Company and demonstrates our commitment in providing both our physician customers and patients one of the most effective body contouring solutions in the market today with clinically proven efficacy,” said
About truSculpt 3D and RF Energy
The truSculpt 3D system utilizes a controlled, monopolar radio frequency (RF) technology to deliver targeted, uniform heating of the subcutaneous adipose tissue to achieve what we believe to be the highest clinical efficacy in the shortest possible treatment time. Focusing on three specific characteristics – dimension, definition, and depth – truSculpt® 3D offers an optimized and customizable approach to body sculpting for most size areas, large or small.
The truSculpt RF energy is intended to provide topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation. Additionally, the 2 MHz setting for the 40 cm2 handpiece is indicated for reduction in circumference of the abdomen and non-invasive lipolysis (breakdown of fat) of the abdomen. The truSculpt massage device is intended to provide a temporary reduction in the appearance of cellulite.
For more information, please visit the truSculpt product page.
VP, Investor Relations and Corporate Development
Source: Cutera, Inc.